Published in Thorax on May 25, 2007
The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med (2011) 2.87
An official American Thoracic Society clinical practice guideline: classification, evaluation, and management of childhood interstitial lung disease in infancy. Am J Respir Crit Care Med (2013) 1.84
miR-31 dysregulation in cystic fibrosis airways contributes to increased pulmonary cathepsin S production. Am J Respir Crit Care Med (2014) 1.45
New molecular detection tools adapted to emerging rhinoviruses and enteroviruses. J Clin Microbiol (2009) 1.27
Proteases and cystic fibrosis. Int J Biochem Cell Biol (2008) 1.25
Arginase and pulmonary diseases. Naunyn Schmiedebergs Arch Pharmacol (2008) 1.16
Corticosteroid responsiveness and clinical characteristics in childhood difficult asthma. Eur Respir J (2009) 1.13
Alveolar inflammation in cystic fibrosis. J Cyst Fibros (2010) 1.11
Lung clearance index and high-resolution computed tomography scores in primary ciliary dyskinesia. Am J Respir Crit Care Med (2013) 1.04
Plasma TGF-β₁ in pediatric cystic fibrosis: potential biomarker of lung disease and response to therapy. Pediatr Pulmonol (2011) 0.98
Elevated furin levels in human cystic fibrosis cells result in hypersusceptibility to exotoxin A-induced cytotoxicity. J Clin Invest (2007) 0.98
Update of respiratory tract disease in children with primary ciliary dyskinesia. Proc Am Thorac Soc (2011) 0.98
Inflammasome-mediated IL-1β production in humans with cystic fibrosis. PLoS One (2012) 0.95
Evaluation of the ability of LL-37 to neutralise LPS in vitro and ex vivo. PLoS One (2011) 0.95
Myofibroblast differentiation and enhanced TGF-B signaling in cystic fibrosis lung disease. PLoS One (2013) 0.95
Hypertonic saline in treatment of pulmonary disease in cystic fibrosis. ScientificWorldJournal (2012) 0.92
Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis. J Inflamm Res (2013) 0.91
Tgf-β1 inhibits Cftr biogenesis and prevents functional rescue of ΔF508-Cftr in primary differentiated human bronchial epithelial cells. PLoS One (2013) 0.90
Tracking the immunopathological response to Pseudomonas aeruginosa during respiratory infections. Sci Rep (2016) 0.90
Passive smoking impairs histone deacetylase-2 in children with severe asthma. Chest (2014) 0.87
Sputum desmosine during hospital admission for pulmonary exacerbation in cystic fibrosis. Chest (2009) 0.86
Dysregulated proinflammatory and fibrogenic phenotype of fibroblasts in cystic fibrosis. PLoS One (2013) 0.85
Antiproteases as therapeutics to target inflammation in cystic fibrosis. Open Respir Med J (2010) 0.84
Identification of neutrophil activation markers as novel surrogate markers of CF lung disease. PLoS One (2014) 0.81
Pharmacokinetics of doxycycline in adults with cystic fibrosis. Antimicrob Agents Chemother (2011) 0.81
Hematopoietic and mesenchymal stem cells for the treatment of chronic respiratory diseases: role of plasticity and heterogeneity. ScientificWorldJournal (2014) 0.79
Clinical features of allergic bronchopulmonary aspergillosis in Korea. Allergy Asthma Immunol Res (2012) 0.76
Role of IRE1α/XBP-1 in Cystic Fibrosis Airway Inflammation. Int J Mol Sci (2017) 0.75
Inhaled hypertonic saline for cystic fibrosis: Reviewing the potential evidence for modulation of neutrophil signalling and function. World J Crit Care Med (2015) 0.75
Airway remodeling in asthma: what really matters. Cell Tissue Res (2017) 0.75
Primary ciliary dyskinesia presenting with spontaneous pneumothorax: Case report and review of the literature. Respir Med Case Rep (2017) 0.75
Efficacy of Rhesus Theta (θ)-Defensin-1 in Experimental Models of Pseudomonas aeruginosa Lung Infection and Inflammation. Antimicrob Agents Chemother (2017) 0.75
Standardization of Spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med (1995) 33.41
Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med (2003) 9.78
Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med (1995) 6.56
Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med (2000) 5.82
Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med (2005) 5.51
The diagnosis of cystic fibrosis: a consensus statement. Cystic Fibrosis Foundation Consensus Panel. J Pediatr (1998) 5.08
Remodeling in asthma and chronic obstructive lung disease. Am J Respir Crit Care Med (2001) 3.59
Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med (1995) 3.47
The role of transforming growth factor beta in lung development and disease. Chest (2004) 2.83
Primary ciliary dyskinesia: diagnosis and standards of care. Eur Respir J (1998) 2.81
Transforming growth factor-beta expression in mucosal biopsies in asthma and chronic bronchitis. Am J Respir Crit Care Med (1997) 2.47
Sputum metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med (1998) 2.36
Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med (2005) 2.26
Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis (1985) 2.04
Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis. Pediatr Pulmonol (2005) 2.00
Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med (2003) 1.94
Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. J Infect Dis (1997) 1.76
Airway function in infants newly diagnosed with cystic fibrosis. Lancet (2001) 1.72
Transforming growth factor-beta 1 in asthma. Measurement in bronchoalveolar lavage fluid. Am J Respir Crit Care Med (1997) 1.64
Structural changes to airway smooth muscle in cystic fibrosis. Thorax (2005) 1.62
The role of IL-13 in established allergic airway disease. J Immunol (2002) 1.48
Enhanced proteoglycan deposition in the airway wall of atopic asthmatics. Am J Respir Crit Care Med (1999) 1.43
Variation in the measurements of basement membrane thickness and inflammatory cell number in bronchial biopsies. Eur Respir J (1998) 1.32
Extracellular matrix and the regulation of lung development and repair. FASEB J (1992) 1.31
Elastin and collagen degradation products in urine of patients with cystic fibrosis. Am J Respir Crit Care Med (1995) 1.23
Airway inflammation in childhood asthma. Am J Respir Crit Care Med (2003) 1.21
The evolution of airway function in early childhood following clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med (2004) 1.20
Matrix metalloproteases in BAL fluid of patients with cystic fibrosis and their modulation by treatment with dornase alpha. Thorax (2002) 1.13
Correlation between cough frequency and airway inflammation in children with primary ciliary dyskinesia. Pediatr Pulmonol (2005) 1.11
On the functional consequences of bronchial basement membrane thickening. J Appl Physiol (1985) (2001) 1.04
Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. Eur Respir J (1999) 1.01
Balance in asthma between matrix metalloproteinases and their inhibitors. J Allergy Clin Immunol (1999) 0.94
Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis. Am J Respir Cell Mol Biol (1991) 0.92
Extracellular matrix regulates human airway smooth muscle cell migration. Eur Respir J (2004) 0.92
Subepithelial fibrosis and degradation of the bronchial extracellular matrix in cystic fibrosis. Am J Respir Crit Care Med (1998) 0.89
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol (2011) 21.49
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med (2014) 10.62
International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J (2013) 8.39
Lung cancer: intragenic ERBB2 kinase mutations in tumours. Nature (2004) 8.35
Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res (2005) 7.66
High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2005) 7.20
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
A screen of the complete protein kinase gene family identifies diverse patterns of somatic mutations in human breast cancer. Nat Genet (2005) 6.70
Induction of epithelial-mesenchymal transition in alveolar epithelial cells by transforming growth factor-beta1: potential role in idiopathic pulmonary fibrosis. Am J Pathol (2005) 5.88
Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart. J Thorac Oncol (2015) 5.83
Lumacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR. N Engl J Med (2015) 5.51
Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients. Am J Respir Crit Care Med (2012) 5.21
Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. JAMA (2010) 4.08
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis. N Engl J Med (2011) 3.85
Non-small-cell lung cancer. Lancet (2011) 3.45
Genomic and genic deletions of the FOX gene cluster on 16q24.1 and inactivating mutations of FOXF1 cause alveolar capillary dysplasia and other malformations. Am J Hum Genet (2009) 3.42
Neutrophil/lymphocyte ratio and its association with survival after complete resection in non-small cell lung cancer. J Thorac Cardiovasc Surg (2008) 3.21
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Fibrotic idiopathic interstitial pneumonia: the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med (2003) 3.07
Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med (2002) 3.06
Relationship between serum vitamin D, disease severity, and airway remodeling in children with asthma. Am J Respir Crit Care Med (2011) 3.00
The Th17 pathway in cystic fibrosis lung disease. Am J Respir Crit Care Med (2011) 2.87
Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography. Am J Respir Crit Care Med (2003) 2.78
Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial. Lancet (2008) 2.77
DICER1 syndrome: clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet (2011) 2.52
Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med (2012) 2.46
Changes in physiological, functional and structural markers of cystic fibrosis lung disease with treatment of a pulmonary exacerbation. Thorax (2013) 2.42
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society: international multidisciplinary classification of lung adenocarcinoma: executive summary. Proc Am Thorac Soc (2011) 2.39
Longitudinal evaluation of airway function 21 years after preterm birth. Am J Respir Crit Care Med (2008) 2.35
The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms. J Thorac Oncol (2011) 2.31
Airway remodeling and inflammation in symptomatic infants with reversible airflow obstruction. Am J Respir Crit Care Med (2005) 2.26
Quantitative analysis of mycobacterial and propionibacterial DNA in lymph nodes of Japanese and European patients with sarcoidosis. J Clin Microbiol (2002) 2.21
Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis. Thorax (2013) 2.17
New respiratory enterovirus and recombinant rhinoviruses among circulating picornaviruses. Emerg Infect Dis (2009) 2.16
Intraoperative pleural lavage cytology is an independent prognostic indicator for staging non-small cell lung cancer. J Thorac Cardiovasc Surg (2004) 2.14
Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med (2007) 2.13
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia: an under-recognised spectrum of disease. Thorax (2006) 2.10
Early detection of airway wall remodeling and eosinophilic inflammation in preschool wheezers. Am J Respir Crit Care Med (2007) 2.09
CDKN2A, NF2, and JUN are dysregulated among other genes by miRNAs in malignant mesothelioma -A miRNA microarray analysis. Genes Chromosomes Cancer (2009) 2.09
Mutations in radial spoke head protein genes RSPH9 and RSPH4A cause primary ciliary dyskinesia with central-microtubular-pair abnormalities. Am J Hum Genet (2009) 2.07
Quality, size, and composition of pediatric endobronchial biopsies in cystic fibrosis. Chest (2007) 2.05
The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev (2011) 2.05
Reproducibility of histopathological diagnosis in poorly differentiated NSCLC: an international multiobserver study. J Thorac Oncol (2014) 2.04
Rapid diagnosis of primary ciliary dyskinesia: cell culture and soft computing analysis. Eur Respir J (2012) 2.04
Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening. Thorax (2012) 2.01
Diagnosis of lung cancer in small biopsies and cytology: implications of the 2011 International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification. Arch Pathol Lab Med (2012) 1.98
Diminished prostaglandin E2 contributes to the apoptosis paradox in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 1.97
The role of surgery in the treatment of limited disease small cell lung cancer: time to reevaluate. J Thorac Oncol (2008) 1.96
Increased local expression of coagulation factor X contributes to the fibrotic response in human and murine lung injury. J Clin Invest (2009) 1.96
Prognostic implications of histologic patterns in multiple surgical lung biopsies from patients with idiopathic interstitial pneumonias. Chest (2004) 1.95
Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med (2003) 1.94
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94
A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest (2003) 1.92
An assessment of the expanded classification of congenital cystic adenomatoid malformations and their relationship to malignant transformation. Am J Surg Pathol (2003) 1.91
Practice imperfect--treatment for wheezing in preschoolers. N Engl J Med (2009) 1.90
Generic detection of coronaviruses and differentiation at the prototype strain level by reverse transcription-PCR and nonfluorescent low-density microarray. J Clin Microbiol (2007) 1.89
Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax (2012) 1.88
Prevalence of asthma among Qatari schoolchildren: International Study of Asthma and Allergies in Childhood, Qatar. Pediatr Pulmonol (2006) 1.88
Increased incidence and severity of the systemic inflammatory response syndrome in patients deficient in mannose-binding lectin. Intensive Care Med (2004) 1.86
Cystic fibrosis. BMJ (2007) 1.82
Lung function from infancy to the preschool years after clinical diagnosis of cystic fibrosis. Am J Respir Crit Care Med (2008) 1.79
Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax (2011) 1.73
Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood (2003) 1.73
Lung clearance index in primary ciliary dyskinesia and bronchiectasis. Am J Respir Crit Care Med (2014) 1.73
CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol (2008) 1.73
Evolving concepts in the pathology and computed tomography imaging of lung adenocarcinoma and bronchioloalveolar carcinoma. J Clin Oncol (2005) 1.69
Airway remodelling and its relationship to inflammation in cystic fibrosis. Thorax (2010) 1.67
Voriconazole therapy in children with cystic fibrosis. J Cyst Fibros (2005) 1.67
Pleuroparenchymal fibroelastosis: a spectrum of histopathological and imaging phenotypes. Eur Respir J (2012) 1.67
Sputum inflammatory phenotypes are not stable in children with asthma. Thorax (2012) 1.65
Repeatability of sodium and chloride in exhaled breath condensates. Pediatr Pulmonol (2004) 1.63
High tidal volume upregulates intrapulmonary cytokines in an in vivo mouse model of ventilator-induced lung injury. J Appl Physiol (1985) (2003) 1.62
Bronchioloalveolar carcinoma in congenital cystic adenomatoid malformation of lung. Ann Thorac Surg (2007) 1.58
Clinical use of noninvasive measurements of airway inflammation in steroid reduction in children. Am J Respir Crit Care Med (2005) 1.56
Gene expression profiling reveals novel TGFbeta targets in adult lung fibroblasts. Respir Res (2004) 1.55
Beta-defensin genomic copy number is not a modifier locus for cystic fibrosis. J Negat Results Biomed (2005) 1.55
Obliterative bronchiolitis in fibreglass workers: a new occupational disease? Occup Environ Med (2013) 1.54
Genotyping in primary ciliary dyskinesia: ready for prime time, or a fringe benefit? Thorax (2012) 1.52
Cystic primary pulmonary synovial sarcoma presenting as recurrent pneumothorax: report of 4 cases. Am J Surg Pathol (2010) 1.49
Multiple-breath washout as a marker of lung disease in preschool children with cystic fibrosis. Am J Respir Crit Care Med (2004) 1.49
Symptom-pattern phenotype and pulmonary function in preschool wheezers. J Allergy Clin Immunol (2010) 1.48
Programmed Death-Ligand 1 Immunohistochemistry in Lung Cancer: In what state is this art? J Thorac Oncol (2015) 1.48
An update on paediatric asthma. Eur Respir Rev (2012) 1.46